-The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen s tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small.
US FDA Approves Amgen Drug for Small Cell Lung Cancer usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
FDA approves Amgen drug for small cell lung cancer | Honolulu Star-Advertiser staradvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from staradvertiser.com Daily Mail and Mail on Sunday newspapers.